Traitement des cancers du poumon localisés au thorax

Depierre, 2003, Bull. Cancer, 90, 151 Van Meerbeeck, 2005, A randomized trial of radical surgery (S) versus thoracic radiotherapy (TRT) in patients (pts) with stage IIIA-N2 non-small cell lung cancer (NSCLC) after response to induction chemotherapy (ICT) (EORTC 08941), Proc. Am. Soc. Clin. Oncol., 23 Eberhardt, 1998, Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial, J. Clin. Oncol., 16, 622, 10.1200/JCO.1998.16.2.622 Albain, 2005, Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): outcomes update of North American Intergroup 0139 (RTOG 9309), Proc. Am. Soc. Clin. Oncol., 23, A7014, 10.1200/jco.2005.23.16_suppl.7014 1995, Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials, BMJ, 311, 899, 10.1136/bmj.311.7010.899 Furuse, 1999, Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer, J. Clin. Oncol., 17, 2692, 10.1200/JCO.1999.17.9.2692 Zatloukal, 2004, Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study, Lung Cancer, 46, 87, 10.1016/j.lungcan.2004.03.004 Fournel, 2005, Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: groupe Lyon-Saint-Étienne d'oncologie thoracique-groupe francais de pneumocancerologie NPC 95-01 Study, J. Clin. Oncol., 23, 5910, 10.1200/JCO.2005.03.070 Choy, 2003, Proc. Am. Soc. Clin. Oncol., 22, A2564 Huber, 2004, Induction chemotherapy and following simultaneous radiochemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC (stage IIIA/IIIB): update of CT/RT 99/97, Proc. Am. Soc. Clin. Oncol., 22, A7075, 10.1200/jco.2004.22.14_suppl.7075 Belani, 2005, Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol, J. Clin. Oncol., 23, 5883, 10.1200/JCO.2005.55.405 Gervais, 2005, Proc. Am. Ass. Clin. Oncol., 23, A7016, 10.1200/jco.2005.23.16_suppl.7016 Hamada, 2005, Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer, J. Clin. Oncol., 23, 4999, 10.1200/JCO.2005.09.017 Berghmans, 2005, Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature, Lung Cancer, 49, 13, 10.1016/j.lungcan.2005.01.002 Sedrakyan, 2004, Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis, J. Thorac. Cardiovasc. Surg., 128, 414, 10.1016/j.jtcvs.2004.04.027 Hotta, 2004, Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials, J. Clin. Oncol., 22, 3860, 10.1200/JCO.2004.01.153 Bria, 2005, Does adjuvant chemotherapy improve survival in non-small cell lung cancer (NSCLC)? A pooled-analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit, Proc. Am. Soc. Clin. Oncol., 23, A7140, 10.1200/jco.2005.23.16_suppl.7140 Pignon, 2006, Lung adjuvant cisplatin evaluation (LACE): A pooled analysis of five clinical trials including 4,584 patients, Proc. Am. Soc. Clin. Oncol., 24, A7008, 10.1200/jco.2006.24.18_suppl.7008 Strauss, 2006, Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group B (CALGB) protocol 9633, Proc. Am. Soc. Clin. Oncol., 24, A7007, 10.1200/jco.2006.24.18_suppl.7007 Depierre, 2002, Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer, J Clin Oncol, 20, 247, 10.1200/JCO.20.1.247 Goldie, 1979, A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate, Cancer Treat. Rep., 63, 1727